Ventricle Health, a virtual cardiac care provider, has secured $8m in seed financing to expand its heart failure management therapeutic model in association with value-based care groups and payers.
This round was led by RA Capital Management, which was joined by other investors including Waterline Ventures.
The company’s care model focuses on established guideline-directed medical therapy (GDMT) pathways, offering patients the convenience of cardiology care appointments from their homes in three days.
Ventricle Health’s home-based and virtually enabled care model aims to reduce the average annual cost of heart failure care by 30-50%.
Its leadership team is said to include heart failure clinicians, value-based care operators, and digital health innovators.
The start-up is currently operational, providing virtual and home-based clinical services to support accountable care organisations (ACOs), primary care practices, and payer partners in the Mid-Atlantic, Texas, Ohio, and Florida, with plans to expand into more markets.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below formBy GlobalData
Ventricle Health founder Dr. Daniel Bensimhon said: “Our foundational service lines offer a rapid path for either payers or value-based provider groups to connect heart failure patients to high quality cardiology services and provides a model for cardiologists to effectively manage more patients.
“Study after study has shown that getting heart failure patients on appropriate guideline-directed medical therapy can dramatically improve health outcomes and lead to marked reductions in costs and improvements in quality of life in just weeks – yet typically less than 20% of our patients are on these medications even when they come out of the hospital. Ventricle is here to change that.”